The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.
The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.
复制标题
HNF1α调控的lncRNA HNF1A-AS1通过增强SHP-1的磷酸酶活性逆转肝细胞癌的恶性程度
DOI:
10.1186/s12943-018-0813-1
复制
发表时间:
2018-02-21
期刊:
影响因子:
37.3
通讯作者:
Xie WF
中科院分区:
文献类型:
--
作者:
Ding CH;Yin C;Chen SJ;Wen LZ;Ding K;Lei SJ;Liu JP;Wang J;Chen KX;Jiang HL;Zhang X;Luo C;Xie WF
Our previous study has demonstrated that hepatocyte nuclear factor 1α (HNF1α) exerts potent therapeutic effects on hepatocellular carcinoma (HCC). However, the molecular mechanisms by which HNF1α reverses HCC malignancy need to be further elucidated. lncRNA microarray was performed to identify the long noncoding RNAs (lncRNAs) regulated by HNF1α. Chromatin immunoprecipitation and luciferase reporter assays were applied to clarify the mechanism of the transcriptional regulation of HNF1α to HNF1A antisense RNA 1 (HNF1A-AS1). The effect of HNF1A-AS1 on HCC malignancy was evaluated in vitro and in vivo. RNA pulldown, RNA-binding protein immunoprecipitation and the Bio-Layer Interferometry assay were used to validate the interaction of HNF1A-AS1 and Src homology region 2 domain-containing phosphatase 1 (SHP-1). HNF1α regulated the expression of a subset of lncRNAs in HCC cells. Among these lncRNAs, the expression levels of HNF1A-AS1 were notably correlated with HNF1α levels in HCC cells and human HCC tissues. HNF1α activated the transcription of HNF1A-AS1 by directly binding to its promoter region. HNF1A-AS1 inhibited the growth and the metastasis of HCC cells in vitro and in vivo. Moreover, knockdown of HNF1A-AS1 reversed the suppressive effects of HNF1α on the migration and invasion of HCC cells. Importantly, HNF1A-AS1 directly bound to the C-terminal of SHP-1 with a high binding affinity (KD = 59.57 ± 14.29 nM) and increased the phosphatase activity of SHP-1. Inhibition of SHP-1 enzymatic activity substantially reversed the HNF1α- or HNF1A-AS1-induced reduction on the metastatic property of HCC cells. Our data revealed that HNF1A-AS1 is a direct transactivation target of HNF1α in HCC cells and involved in the anti-HCC effect of HNF1α. HNF1A-AS1 functions as phosphatase activator through the direct interaction with SHP-1. These findings suggest that regulation of the HNF1α/HNF1A-AS1/SHP-1 axis may have beneficial effects in the treatment of HCC. The online version of this article (10.1186/s12943-018-0813-1) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
3.2
作者:
Dang Y;Lan F;Ouyang X;Wang K;Lin Y;Yu Y;Wang L;Wang Y;Huang Q
通讯作者:
Huang Q
影响因子:
3
作者:
Muppirala UK;Honavar VG;Dobbs D
通讯作者:
Dobbs D
影响因子:
2.8
作者:
Lopez-Ruiz, Pilar;Rodriguez-Ubreva, Javier;Colas, Begona
通讯作者:
Colas, Begona
影响因子:
50.3
作者:
Hu X;Feng Y;Zhang D;Zhao SD;Hu Z;Greshock J;Zhang Y;Yang L;Zhong X;Wang LP;Jean S;Li C;Huang Q;Katsaros D;Montone KT;Tanyi JL;Lu Y;Boyd J;Nathanson KL;Li H;Mills GB;Zhang L
通讯作者:
Zhang L
影响因子:
19
作者:
Li, Lingjie;Chang, Howard Y.
通讯作者:
Chang, Howard Y.